HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Orbital involvement in multiple myeloma: first sign of insufficient chemotherapy.

Abstract
Orbital involvement in multiple myeloma is unusual. We describe the case of a 60-year-old male who presented with left proptosis, reduced visual acuity, diplopia and progressing signs of globe indentation 2 months after chemotherapy for multiple myeloma. MRI showed a well-defined tumor filling the mediobasal part of the left orbit. Incisional biopsy and reduction of tumor mass were performed using an anterior transconjunctival orbitotomy. Histopathologic findings and further systemic examination confirmed the reactivation of the multiple myeloma. Proptosis, intraocular pressure and visual acuity improved following external beam radiation therapy of the left orbit and repeated systemic chemotherapy. Orbital involvement in multiple myeloma was the only sign of insufficient chemotherapy.
AuthorsUlrike B Kottler, Claus Cursiefen, Leonard M Holbach
JournalOphthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde (Ophthalmologica) 2003 Jan-Feb Vol. 217 Issue 1 Pg. 76-8 ISSN: 0030-3755 [Print] Switzerland
PMID12566878 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright 2003 S. Karger AG, Basel
Chemical References
  • Antineoplastic Agents
  • Biomarkers, Tumor
Topics
  • Antineoplastic Agents (therapeutic use)
  • Biomarkers, Tumor (metabolism)
  • Diplopia (diagnosis)
  • Exophthalmos (diagnosis)
  • Humans
  • Immunohistochemistry
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Multiple Myeloma (drug therapy, pathology, radiotherapy)
  • Orbital Neoplasms (drug therapy, pathology, radiotherapy)
  • Treatment Failure
  • Vision Disorders (diagnosis)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: